Aamdal E, Inderberg EM, Ellingsen EB, Rasch W, Brunsvig PF, Aamdal S, Heintz KM, Vodák D, Nakken S, Hovig E, Nyakas M, Guren TK, Gaudernack G(2021) Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial Front Immunol, 12, 663865 DOI 10.3389/fimmu.2021.663865, PubMed 34046035
Aamdal E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Schuster C, Hagene KT, Holmsen K, Russnes HG, Skovlund E, Kaasa S, Aamdal S, Kyte JA, Guren TK(2021) Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up Int J Cancer(in press) DOI 10.1002/ijc.33768, PubMed 34449877
Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT(2021) One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison Eur J Surg Oncol, 47(7), 1651-1660 DOI 10.1016/j.ejso.2021.01.011, PubMed 33518367
